附近上门

, an Austin-based healthcare and life science-focused venture firm, has raised $250 million in its third fund.

Subscribe to the 附近上门 Daily

The amount is significantly higher than the $132 million and $139 million raised in the firm鈥檚 , which closed in 2007 and 2011, respectively.

, co-founder and managing director of Sant茅 Ventures, said the firm plans to make 20-25 new early-stage investments out of the new fund. It鈥檚 already made three deals so far (equal to about 6.5 percent of its capital), putting money into San Jose-based , which is developing treatment of sleep apnea; , a Minnesota company focused on a treatment of Type II diabetes, and , a neoantigen-based personalized cancer therapy with headquarters in Pennsylvania.

The new fund was about 25 percent oversubscribed, according to Sant茅, and included more than 30 limited partners. $75 million to Fund III, and another $75 million to a planned Fund IV. It also contributed to Sant茅鈥檚 first two funds.

Founded in 2006, Sant茅 has invested in a total of 33 companies, including the three startups referenced above. It鈥檚 had nearly a dozen , according to its 附近上门 profile, including scooping up () and (); acquiring and purchasing .

About 40 percent of the firm鈥檚 portfolio is made up of Texas companies. But Lalande points out that some companies鈥� technologies originated in other locales but were moved to the area so that the investors could be physically closer to help them scale.

鈥淲ith many of our portfolio companies, we either created them or were the first investor,鈥� Lalande told 附近上门 News. 鈥淲e usually write the first check and support a company all the way to the end.鈥�

Sant茅 says that it is looking for 鈥渃ompelling opportunities鈥� 聽in the medtech, biotech, digital health, and health care services sectors. It has an office in Houston鈥檚 (for obvious reasons) and is the only VC firm focused on the space in the Austin area.

Previously, Lalande spent seven years at the now-defunct .

Illustration: